e-learning
resources
London 2016
Monday, 05.09.2016
Multidimensional and multidisciplinary approaches to respiratory problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Altitude related adverse health effects in lowlanders with COPD travelling to 3200m
Michael Furian (Zurich, Switzerland), Michael Furian, Mona Lichtblau, Sayaka S. Aeschbacher, Maya Bisang, Sara E. Hartmann, Marc Poulin, Tsogyal D. Latshang, Silvia Ulrich, Almaz Aldashev, Talant Sooronbaev, Konrad E. Bloch
Source:
International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Session:
Multidimensional and multidisciplinary approaches to respiratory problems
Session type:
Thematic Poster
Number:
2204
Disease area:
Airway diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Michael Furian (Zurich, Switzerland), Michael Furian, Mona Lichtblau, Sayaka S. Aeschbacher, Maya Bisang, Sara E. Hartmann, Marc Poulin, Tsogyal D. Latshang, Silvia Ulrich, Almaz Aldashev, Talant Sooronbaev, Konrad E. Bloch. Altitude related adverse health effects in lowlanders with COPD travelling to 3200m. Eur Respir J 2016; 48: Suppl. 60, 2204
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
Exercise performance in lowlanders with COPD travelling to 2048m
Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Year: 2018
Effect of travelling to 2590m on 6-minute walk distance, blood gases and symptoms of acute mountain sickness in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Cerebral oxygenation in lowlanders with COPD spending a night at 2590m
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Breathing and sleep disturbances in lowlanders with COPD travelling to 2590m
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Postural control in COPD patients travelling from 760 m to 3200 m; randomized trial evaluating effects of dexamethasone
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016
Cerebral oxygen availability limits exercise performance of lowlanders with chronic obstructive pulmonary disease (COPD) travelling to 2590m
Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease
Year: 2015
Modeling an electronic field registry - An adaptation approach to climate change in mild altitude cities for early prediction of heat related COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Blood eosinophil levels and exacerbations in a cohort of biomass and tobacco-related COPD patients at high altitude (2600 m)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020
The major limitation to exercise tolerance in COPD patients at Bogota (2640m) is hypoxemia
Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Year: 2010
COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006
Preparing asthmatic patients to climb to extreme high altitude (asthma Aconcagua expedition)
Source: Annual Congress 2011 - Phenotyping airway diseases
Year: 2011
Does climate change induce more heat stress related COPD exacerbations in metropolitan Berlin?
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Dexamethasone treatment for patients with COPD when they travel to high altitude
Source: International Congress 2019 – Advances in chronic obstructive pulmonary disease and asthma
Year: 2019
Short term impact of air pollution on asthma and COPD in Tirana during 1 year period
Source: International Congress 2015 – Indoor air and ambient pollution
Year: 2015
Do air pollution and outdoor temperature influence the frequency of acute COPD exacerbations?
Source: International Congress 2016 – The indoor and ambient environments
Year: 2016
Late Breaking Abstract - The socio-economic cost of asthma, COPD and chronic bronchitis in Europe.
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Hospital readmissions and social deprivation in asthma and COPD
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Mild cognitive impairment and self reported exacerbation rate in patients with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept